Full Text View
Tabular View
No Study Results Posted
Related Studies
Genetic Factors That Influence Chronic Obstructive Pulmonary Disease in Hispanics
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by National Heart, Lung, and Blood Institute (NHLBI).   Recruitment status was  Recruiting

First Received on March 24, 2005.   Last Updated on July 14, 2009   History of Changes
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00106470
  Purpose

The purpose of this study is to examine genetic factors that influence the development of chronic obstructive pulmonary disease (COPD) in Hispanics, a minority group at high risk for the disease.


Condition
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Cross-Sectional
Official Title: Genetic Epidemiology of COPD in Costa Rica

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Primary Outcome Measures:
  • Genetic factors that influence the development of COPD in Hispanics. [ Time Frame: Measured through the use of genetic samples ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Serum


Estimated Enrollment: 900
Study Start Date: February 2005
Estimated Study Completion Date: January 2010
Detailed Description:

DESIGN NARRATIVE:

This study will concentrate on a genetically isolated Hispanic population with a high prevalence of COPD living in the Central Valley of Costa Rica. Nine hundred individuals from descendants of the Costa Rican Central Valley founder population will be enrolled. To identify regions of the genome that are likely to contain genetic determinants of COPD-related phenotypes in this population, the study will collect phenotypic and genotypic data on 30 large families with a history of moderate to severe COPD that have multiple individuals affected with smoking-related airflow obstruction. A genome scan will be conducted on these individuals using short-tandem repeat (STR) markers. Linkage analysis will be performed on 6 COPD-related phenotypes, which will include the following: 1) chronic bronchitis; 2) airflow obstruction; 3) FEV1; 4) FEV1/FVC; 5) bronchodilator responsiveness; and 6) total serum IgE. Within genomic regions demonstrating linkage to COPD-related phenotypes in the genome scan, narrowly spaced STR markers will be genotyped and tested for linkage between these markers and COPD-related phenotypes. Within selected genomic regions, the association will be tested between single nucleotide polymorphisms (SNPs) in candidate genes and COPD-related phenotypes. By enrolling a large number of participants of a genetically isolated population and utilizing a family-based study design, this study should be able to address an important yet unstudied issue: the genetic influences on the expression of the COPD phenotype in Hispanics.

  Eligibility

Ages Eligible for Study:   21 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Families of individuals with physician-diagnosed COPD and smoking-related airflow obstruction who are younger than 71 years.

Criteria

Inclusion Criteria:

  • COPD
  • Reduced FEV1 after administration of bronchodilator (less than or equal to 60% of predicted value)
  • At least six great-grandparents born in the Central Valley of Costa Rica
  • At least one sibling with a history of smoking (10 or more packs per year)

Exclusion Criteria:

  • Chronic respiratory disorder other than COPD (as determined by a questionnaire and high-resolution CT chest scan)
  • Severe alpha 1-antitrypsin deficiency
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00106470

Contacts
Contact: Manuel E. Soto-Quiros, MD, PhD 011 506 258 0749 msotoq@hnn.sa.cr

Locations
Costa Rica
Hospital Nacional de Niños Recruiting
San José, Costa Rica
Contact: Manuel E. Soto-Quiros, MD, PhD     011-506-258-0749     msotoq@hnn.sa.cr    
Sponsors and Collaborators
Investigators
Study Chair: Juan C. Celedon, MD, DrPH Brigham and Women's Hospital
  More Information

Publications:
Responsible Party: Juan C. Celedon, MD, DrPH (Principal Investigator), Brigham and Women's Hospital, Harvard Medical School
ClinicalTrials.gov Identifier: NCT00106470     History of Changes
Other Study ID Numbers: 1289, R01 HL73373
Study First Received: March 24, 2005
Last Updated: July 14, 2009
Health Authority: United States: Federal Government

Keywords provided by National Heart, Lung, and Blood Institute (NHLBI):
Chronic Obstructive Pulmonary Disease

Additional relevant MeSH terms:
Chronic Disease
Lung Diseases
Respiration Disorders
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Disease Attributes
Pathologic Processes
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on February 09, 2012